SEC CIK 1102444
BIOTECHNOLOGY VALUE FUND II LP
Reported ownership across 10 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CRISview stock → | 7,692,716 | 2009-04-27 |
| CYTKview stock → | 3,811,271 | 2020-12-09 |
| NBIXview stock → | 3,527,700 | 2011-10-12 |
| RGENview stock → | 2,765,050 | 2009-07-07 |
| CTMXview stock → | 2,164,406 | 2020-12-18 |
| VSTMview stock → | 994,353 | 2022-01-25 |
| RIGLview stock → | 646,559 | 2013-11-19 |
| LGNDview stock → | 230,125 | 2014-03-25 |
| XENEview stock → | 216,694 | 2018-03-27 |
| CBIOview stock → | 62,383 | 2025-06-13 |
Position History — RGEN
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — RGEN
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2009-07-07 | Open-market sale | 1,000 | $5.50 | 2,765,050 |
| 2009-07-06 | Open-market sale | 110,800 | $5.52 | 3,106,050 |
| 2009-07-06 | Open-market sale | 264,000 | $5.52 | 2,766,050 |
| 2009-07-06 | Open-market sale | 76,000 | $5.52 | 3,030,050 |
| 2009-05-15 | — | — | — | 825,750 |
| 2009-05-15 | — | — | — | 3,216,850 |
| 2009-05-15 | — | — | — | 3,216,850 |
| 2009-05-15 | — | — | — | 3,216,850 |
| 2009-05-15 | — | — | — | 534,400 |
| 2009-05-15 | — | — | — | 1,856,700 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.